Sesamol-Loaded PLGA Nanosuspension for Accelerating Wound Healing in Diabetic Foot Ulcer in Rats

References

• Yang P, Pei Q, Yu T, et al. Compromised wound healing in ischemic type 2 diabetic rats. PLoS One. 2016;11(3):e0152068–e0152068. doi:10.1371/journal.pone.015206827028201
   PubMed Web of Science ®Google Scholar
• Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res. 2010;89(3):219–229. doi:10.1177/002203450935912520139336
   PubMed Web of Science ®Google Scholar
• Majdalawieh AF, Mansour ZR. Sesamol, a major lignan in sesame seeds (Sesamum indicum): anti-cancer properties and mechanisms of action. Eur J Pharmacol. 2019;855:75–89. doi:10.1016/j.ejphar.2019.05.00831063773
   PubMed Web of Science ®Google Scholar
• Kumar N, Mudgal J, Parihar VK, Nayak PG, Kutty NG, Rao CM. Sesamol treatment reduces plasma cholesterol and triacylglycerol levels in mouse models of acute and chronic hyperlipidemia. Lipids. 2013;48(6):633–638.23504268
   PubMed Web of Science ®Google Scholar
• Parihar VK, Prabhakar KR, Veerapur VP, et al. Effect of sesamol on radiation-induced cytotoxicity in Swiss albino mice. Mutat Res Genet Toxicol Environ Mutagen. 2006;611(1):9–16. doi:10.1016/j.mrgentox.2006.06.037
   Web of Science ®Google Scholar
• Shenoy RR, Sudheendra AT, Nayak PG, Paul P, Kutty NG, Rao CM. Normal and delayed wound healing is improved by sesamol, an active constituent of Sesamum indicum (L.) in albino rats. J Ethnopharmacol. 2011;133(2):608–612. doi:10.1016/j.jep.2010.10.04521035533
   PubMed Web of Science ®Google Scholar
• Jan K-C, Ho C-T, Hwang LS. Bioavailability and tissue distribution of sesamol in rat. J Agric Food Chem. 2008;56(16):7032–7037. doi:10.1021/jf801264718636732
   PubMed Web of Science ®Google Scholar
• Jan K-C, Ho C-T, Hwang LS. Elimination and metabolism of sesamol, a bioactive compound in sesame oil, in rats. Mol Nutr Food Res. 2009;53(S1):S36–S43. doi:10.1002/mnfr.20080021419156718
   PubMedGoogle Scholar
• Geetha T, Singh N, Deol PK, Kaur IP. Biopharmaceutical profiling of sesamol: physiochemical characterization, gastrointestinal permeability and pharmacokinetic evaluation. RSC Adv. 2015;5(6):4083–4091. doi:10.1039/C4RA10926K
   Web of Science ®Google Scholar
• Shao M, Hussain Z, Thu HE, et al. Emerging Trends in Therapeutic Algorithm of Chronic Wound Healers: Recent Advances in Drug Delivery Systems, Concepts-to-Clinical Application and Future Prospects. Crit Rev Ther Drug Carrier Syst 2017;34(5):387–452. doi:10.1615/CritRevTherDrugCarrierSyst.2017016957
   Google Scholar
• Hussain Z, Thu HE, Shuid AN, Katas H, Hussain F. Recent advances in polymer-based wound dressings for the treatment of diabetic foot ulcer: an overview of state-of-the-art. Curr Drug Targets. 2018;19(5):527–550. doi:10.2174/138945011866617070413252328676002
   PubMed Web of Science ®Google Scholar
• Hussain Z, Thu HE, Ng SF, Khan S, Katas H. Nanoencapsulation, an efficient and promising approach to maximize wound healing efficacy of curcumin: a review of new trends and state-of-the-art. Colloids Surf B Biointerfaces. 2017;150:223–241. doi:10.1016/j.colsurfb.2016.11.03627918967
   PubMed Web of Science ®Google Scholar
• Kola Srinivas NS, Verma R, Pai Kulyadi G, Kumar L. A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization. Int J Nanomedicine. 2016;12:15–28. doi:10.2147/IJN.S12272928031710
   PubMed Web of Science ®Google Scholar
• Hirpara MR, Manikkath J, Sivakumar K, et al. Long circulating PEGylated-chitosan nanoparticles of rosuvastatin calcium: development and in vitro and in vivo evaluations. Int J Biol Macromol. 2018;107:2190–2200. doi:10.1016/j.ijbiomac.2017.10.08629042279
   PubMed Web of Science ®Google Scholar
• Fernandes AV, Pydi CR, Verma R, Jose J, Kumar L. Design, preparation and in vitro characterizations of fluconazole loaded nanostructured lipid carriers. Braz J Pharm Sci. 2020;56.
   Web of Science ®Google Scholar
• Bairagi U, Mittal P, Singh J, Mishra B. Preparation, characterization, and in vivo evaluation of nano formulations of ferulic acid in diabetic wound healing. Drug Dev Ind Pharm. 2018;44(11):1783–1796. doi:10.1080/03639045.2018.149644829973105
   PubMed Web of Science ®Google Scholar
• Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacoll Res. 2005;52(4):313–320. doi:10.1016/j.phrs.2005.05.004
   PubMed Web of Science ®Google Scholar
• Shi R, Lian W, Han S, et al. Nanosphere-mediated co-delivery of VEGF-A and PDGF-B genes for accelerating diabetic foot ulcers healing in rats. Gene Ther. 2018;25(6):425–438. doi:10.1038/s41434-018-0027-629955127
   PubMed Web of Science ®Google Scholar
• Hemalatha G, Pugalendi KV, Saravanan R. Modulatory effect of sesamol on DOCA-salt-induced oxidative stress in uninephrectomized hypertensive rats. Mol Cell Biochem. 2013;379(1):255–265. doi:10.1007/s11010-013-1647-123576423
   PubMed Web of Science ®Google Scholar
• Vennila L, Pugalendi KV. Protective effect of sesamol against myocardial infarction caused by isoproterenol in Wistar rats. Redox Rep. 2010;15(1):36–42. doi:10.1179/174329210X1265050662316820196927
   PubMed Web of Science ®Google Scholar
• Muhammad AA, Arulselvan P, Cheah PS, Abas F, Fakurazi S. Evaluation of wound healing properties of bioactive aqueous fraction from Moringa oleifera Lam on experimentally induced diabetic animal model. Drug Des Devel Ther. 2016;10:1715–1730. doi:10.2147/DDDT.S96968
   PubMed Web of Science ®Google Scholar
• Reed MJ, Meszaros K, Entes LJ, et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism. 2000;49(11):1390–1394. doi:10.1053/meta.2000.1772111092499
   PubMed Web of Science ®Google Scholar
• Fowler MJ. Microvascular and macrovascular complications of diabetes mellitus. Clin Diabetes. 2006;26(2):77–82. doi:10.2337/diaclin.26.2.77
   Google Scholar
• Singh K, Agrawal NK, Gupta SK, et al. Decreased expression of heat shock proteins may lead to compromised wound healing in type 2 diabetes mellitus patients. J Diabetes Complications. 2015;29(4):578–588. doi:10.1016/j.jdiacomp.2015.01.00725746357
   PubMed Web of Science ®Google Scholar
• Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest. 2007;117(5):1219–1222. doi:10.1172/JCI3216917476353
   PubMed Web of Science ®Google Scholar
• Xu F, Zhang C, Graves DT. Abnormal cell responses and role of TNF-α in impaired diabetic wound healing. Biomed Res Int. 2013;2013:754802. doi:10.1155/2013/75480223484152
   PubMed Web of Science ®Google Scholar
• Tonnesen MG, Feng X, Clark RAF. Angiogenesis in wound healing. J Investig Dermatol Symp Proc. 2000;5(1):40–46. doi:10.1046/j.1087-0024.2000.00014.x
   PubMed Web of Science ®Google Scholar
• Pastar I, Ojeh N, Glinos GD, Stojadinovic O, Tomic-Canic M. Physiology and pathophysiology of wound healing in diabetes In: Veves A, Giurini JM, Guzman RJ, editors. The Diabetic Foot: Medical and Surgical Management. Cham: Springer International Publishing; 2018:109–130.
   Google Scholar